Generic Names of Some Trade Name Drugs, THE MERCK MANUAL OF HEALTH & AGING Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - APPENDIX I - Drug Names: Generic and Trade TOPICS - Introduction -~ Some Trade Names of Generic Drugs -~ Generic Names of Some Trade Name Drugs - Generic Names of Some...
Some Trade Names of Generic Drugs, THE MERCK MANUAL OF HEALTH & AGING Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - APPENDIX I - Drug Names: Generic and Trade TOPICS - Introduction -~ Some Trade Names of Generic Drugs-~ Generic Names of Some Trade Name Drugs - Some Trade Names of...
THE MERCK MANUAL OF GERIATRICS, App. III, Trade Names of Some Commonly Used Drugs, ABBOKINASE to BUTAZOLIDIN Trade Names of Some Commonly Used Drugs TRADE AND GENERIC NAMES OF COMMONLY USED DRUGS ABBOKINASE to BUTAZOLIDIN Trade Name Generic ABBOKINASE Urokinase ACCOLATE Zafirlukast ACCUPRIL Quinapril ACCUTANE Isotretinoin ACHROM YCIN V Tetracycline ACTHAR Corticotropin (ACTH) ACTIFED *Triprolidine ADALAT Nifedipine ADENOCARD Adenosine ADRIAMYCIN Doxorubicin ADVIL Ibuprofen AFRIN...
Sulfonylureas for type 2 diabetes - [Medication] - Quest Diagnostics Patient Health Library Topic Contents - Examples - How It Works - Why It Is Used - How Well It Works - Side Effects - What To Think About - References Sulfonylureas for type 2 diabetes - [Medication] - Quest Diagnostics Patient Health Library Sulfonylureas for type 2 diabetes - [Medication] - Quest Diagnostics Patient Health Library Adult Diabetes, adult onset diabetes, adult onset diabetes mellitus, ...
http://www.perrigo.com/upload/news_ir_141.pdf page 1
http://www.biosis.org/ts/media/cdjournals/gazettenews/2003/CPG_News_0329.pdf Drug Patenting in Context ISSN:1464-3499 week 0329 18 July 2003 Sun Pharmaceuticals continues to develop its generic portfolio with applications relating to Aventis Pharm’s glimepiride (right) and Lundbeck’s citalopram.
http://www.fda.gov/cder/orange/appendix_a.txt 3, ACETAMINOPHEN ACETAMINOPHEN W/ CODEINE PHOSPHATE #3, ACETAMINOPHEN ACETAMINOPHEN W/ CODEINE PHOSPHATE, ACETAMINOPHEN ACETAMINOPHEN W/ CODEINE, ACETAMINOPHEN ACETAMINOPHEN, ACETAMINOPHEN (OTC) ACETAMINOPHEN, ASPIRIN AND CAFFEINE, ACETAMINOPHEN (OTC) ACETAMINOPHEN, ASPIRIN, AND CODEINE PHOSPHATE, ACETAMINOPHEN ACETAMINOPHEN, BUTALBITAL AND CAFFEINE, ACETAMINOPHEN ACETAMINOPHEN,...
THE MERCK MANUAL OF GERIATRICS, App. III, Trade Names of Some Commonly Used Drugs, ABBOKINASE to BUTAZOLIDIN Trade Names of Some Commonly Used Drugs TRADE AND GENERIC NAMES OF COMMONLY USED DRUGS ABBOKINASE to BUTAZOLIDIN Trade Name Generic ABBOKINASE Urokinase ACCOLATE Zafirlukast ACCUPRIL Quinapril ACCUTANE Isotretinoin ACHROMYCIN V Tetracycline ACTHAR Corticotropin (ACTH) ACTIFED *Triprolidine ADALAT Nifedipine ADENOCARD Adenosine ADRIAMYCIN Doxorubicin ADVIL Ibuprofen AFRIN...
THE MERCK MANUAL OF GERIATRICS, App. III, Trade Names of Some Commonly Used Drugs, Factor IX concentrates to Itraconazole Trade Names of Some Commonly Used Drugs GENERIC AND TRADE NAMES OF COMMONLY USED DRUGS Factor IX concentrates to Itraconazole Generic Trade Name Factor IX concentrates KONYNE 80, PROPLEX T Famciclovir FAMVIR Famotidine PEPCID Felodipine PLENDIL Fenfluramine PONDIMIN Fenoprofen NALFON Fentanyl SUBLIMAZE Fexofenadine ALLEGRA Filgrastim NEUPOGEN Finasteride PROSCAR, PROPECIA Flavoxate...
Prescription and Over-the-Counter Drug Product List: 1/2003 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; BUTALBITAL; CAFFEINE -A- SOLUTION; ORAL -A- ACETAMINOPHEN AND BUTALBITAL AND CAFFEINE -A- + MIKART 325MG/15ML;50MG/15ML;40MG/15ML N40387 001 JAN 31, 2003 JAN NEWA ACETAMINOPHEN; CODEINE PHOSPHATE TABLET; ORAL ACETAMINOPHEN AND CODEINE PHOSPAHTE -A- AA ANDRX PHARMS 300MG;15MG N40443 001 JAN 22, 2003 JAN NEWA -A- AA...
author: AUTHOR
FDA Drug Approvals List April 2002 JOHNSON PHARMACEUTICAL RESEARCH INSTITUTE Active Ingredient(s): HALOPERIDOL OTC/RX Status: RX Application #: 011340 Labeling Supplement #: 016 To Original New Drug Application Approval Date: 17-APR-02 Trade Name: CERUMENEX Dosage Form: SOLUTION Applicant: PURDUE FREDERICK CO Active Ingredient(s): TRIETHANOLAMINE POLYPEPTIDE OLEATE CONDENSATE OTC/RX Status: OTC Application #: 010596...
CW0907_Jul02.qxd page 19
author: Liz
Diabetes Monitor: Glimepiride The Diabetes Monitor: Glimepiride (Amaryl) information. ...
http://www.fda.gov/cder/rdmt/escy99ap.htm EFFICACY SUPPLEMENTS APPROVED IN CY 99 GENERIC NAME APPLICANT NDA NUMBER RECEIPT DATE APPROVAL DATE SUPP TYPE SUPP NUMBER PRIOITY REVIEW TOTAL APPROVAL TIME (MONTHS) INDICATION/DESCRIPTION - - - - - - - - - - ATOVAQUONE GLAXO WELLCOME 20-500 03/06/98 01/05/99 SE1 5 N 10.0 Prevention of Pneumocystis carinii pneumonia (PCP)GLIMEPIRIDE HOECHST MARION RSSL...
author: Darlene
FDA Drug Approvals List September 2000 Original Application #: 021251 Approval Date: 15-SEP-00 Trade Name: KALETRA Chemical Type: Therapeutic Potential: Dosage Form: SOLUTION Applicant: ABBOTT LABORATORIES Active Ingredient(s): LOPINAVIR OTC/RX Status: RX Indication(s): For the treatment of HIV-1 infection in adults and pediatric patients age six months and older Original Application #: 021226 Approval Date: 15-SEP-00...
cpmp_ref_343_96 The European Agency for the Evaluation of Medicinal Products 7 Westferry Circus, Canary Wharf, London E14 4HB, UK Switchboard: (+ 44- 171) 418 8400 Fax: (+ 44- 171) 418 8551 E_ Mail: mail@ emea. eudra. org http:// www. eudra. org/ emea. html ãEMEA 1998 Reproduction and/ or distribution of this document ...
author: WELLS
cpmp_ref_343_96 page 14 CPMP/ 343/ 96 ãEMEA 1998 14/ 14 OVERALL SUMMARY OF THE SCIENTIFIC EVALUATION OF AMARYL 1. Safety issue in relation to uterine adenocarcinomas in rats Glimepiride caused a slightly higher incidence (14%) of uterine adenocarcinomas in female rats at a level of 345 mg/ kg/ day than in those treated with ...
author: WELLS
cpmp_ref_343_96 page 12 CPMP/ 343/ 96 ãEMEA 1998 12/ 14 Glimepiride did not show any mutagenic or genotoxic effects. Glimepiride caused a slight increased incidence of uterine adenocarcinomas in rats at a dose level of 345 mg/ kg/ day. The safety factors based on a comparison of systemic exposure (AUC values) of female rats ...
author: WELLS
cpmp_ref_343_96 page 10 CPMP/ 343/ 96 ãEMEA 1998 10/ 14 In placebo controlled studies upper respiratory tract infections were more frequent with glimepiride (14.2%) than with placebo (7.8%). This was in no case considered treatment related by the investigator. Incidence of upper respiratory tract infections was similar ...
author: WELLS
cpmp_ref_343_96 page 8 CPMP/ 343/ 96 ãEMEA 1998 8/ 14 In stress- situations (e. g. accidents, acute operations, infections with fever, etc.) a temporary switch to insulin may be indicated. No experience has been gained concerning the use of Amaryl in patients with severe impairment of liver function or dialysis patients. ...
author: WELLS
cpmp_ref_343_96 page 1 The European Agency for the Evaluation of Medicinal Products 7 Westferry Circus, Canary Wharf, London E14 4HB, UK Switchboard: (+ 44- 171) 418 8400 Fax: (+ 44- 171) 418 8551 E_ Mail: mail@ emea. eudra. org http:// www. eudra. org/ emea. html ãEMEA 1998 Reproduction and/ or distribution of this document ...
author: WELLS
cpmp_ref_1416_98 The European Agency for the Evaluation of Medicinal Products Human Medicines Evaluation Unit 7 Westferry Circus, Canary Wharf, London E14 4HB, UK Switchboard: (+ 44- 171) 418 8400 Fax: (+ 44- 171) 418 8551 E_ Mail: mail@ emea. eudra. org http:// www. eudra. org/ emea. html ãEMEA 1998 Reproduction ...
author: WELLS
DDPA November 1995 DEPARTMENT OF HEALTH AND HUMAN SERVICES, PUBLIC HEALTH SERVICE NDA NUMBER TRADE NAME APPLICANT ACTIVE INGREDIENT(S) APPROVAL DATE (DOSAGE FORM) STRENGTH(S) (CLASSIFICATION) CLASSIFICATION(S) ***ORIGINAL AND SUPPLEMENTAL NDAs*** FOR NEW DRUG PRODUCTS 20-401 TIAZAC BIOVAIL DILTIAZEM HYDROCHLORIDE 11-SEP-95 (CAPSULE, SCARBOROUGH, ONTARIO 120MG (3 S) EXTENDED RELEASE) CANADA 180MG 240MG...
Perrigo | Newsroom | Press Releases document.write(' ') Recent News Releases For additional media information contact: Ernie Schenk eschenk@perrigo.com 269-673-9212 (direct) 269-673-9128 (fax) Perrigo Company Announces Dividend Increase Oct 28, 2005 Board declares quarterly dividend of $0.0425 per share.Glimepiride Tablets Oct 7, 2005 Final approval...
Index G, THE MERCK MANUAL OF HEALTH & AGING Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - INDEX - Index-A -~ Index-B -~ Index-C -~ Index-D -~ Index-E -~ Index-F -~ Index-G-~ Index-H -~ Index-I -~ Index-J -~ Index-K -~ Index-L -~ Index-M -~ Index-N -~ Index-O ...
